Navigation Links
InterHealth Nutraceuticals Announced Last Week that UC-II® Undenatured Type II Collagen Receives Top Honors at the 2013 Natural Supplements Research Competition

Salt Lake City, UT (PRWEB) September 30, 2013

InterHealth Nutraceutical announced last week that one of the company’s nutritional ingredients received top honors at the 2013 Natural Supplement Research Competition hosted by the Scripps Center for Integrative Medicine. The competition-winning research presented by Medicus Research on UC-II® Undenatured Type II Collagen is considered to be groundbreaking new information in the battle against Osteoarthritis and joint pain relief.

The annual research competition brings together medical professionals from around the world to discuss breakthroughs and trends within the dietary supplement industry. Participants in the research competition presented a mixture of original clinical research and basic science and review entries. Awards were presented in both faculty and student categories, with entries judged in areas such as originality, design, and interpretation.

This year’s winning entry submitted by Medicus Research concluded that, “Supplementation with UC-II® for seventeen weeks was well-tolerated and more effective than placebo in supporting joint comfort, flexibility, and mobility.” The research further noted that, “UC-II® Undenatured Type II Collagen appears to be effective in alleviating joint discomfort.” [JACM, 2013; 19:A4]

UC-II® was developed by a team of scientists at InterHealth Nutraceutical with more than 25 years of experience in the development of patented, clinically proven dietary ingredients. It holds 7 international and U.S. patents and is supported by 9 human clinical studies, including research at Harvard Medical School.

UC-II® is the active ingredient found in TFX Flex™ and other popular joint health supplements that offer clinically proven joint pain relief.

A company spokesman from TFX Health, makers of the popular TFX Flex™ joint health supplement explained, “The science behind joint health is rapidly changing. Glucosamine & chondroitin are no longer the only options for joint pain relief and certainly not the best option. TFX Flex™ with UC-II® has been proven in clinical studies to be 2X more effective than glucosamine and chondroitin and may offer joint pain relief in as little as 7 days.” [Int J Med Sci. 2009; 6:312-321].

To learn more about UC-II® Undenatured Type II Collagen, please visit or

About TFX Health, LLC

Based in Salt Lake City, TFX Health, LLC is an innovative pioneer in the development of advanced health and wellness products. All products are manufactured in the USA in FDA registered, GMP compliant facilities and sold worldwide through online and traditional retail channels.

UC-II® is a trademark of InterHealth N.I. Clinical data available upon request. U.S. Patents 5,645,851; 5,637,321; 5,529,786; 5,750,144; 7,083,820; 7,846,487, EPO Patent 1435906B1 and worldwide patents pending.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fertility Nutraceuticals, LLC Announces Release of OVOENERGEN™ CoQ10 Fertility Supplement for Women
2. Monterey Bay Nutraceuticals Now Taking Advance Orders Online
3. Monterey Bay Nutraceuticals Announces Launch of Website
4. Liproxenol Nutraceuticals found that Liproxenol Has Been Named The Top Finisher For “Best Diet Pills Of 2012”
5. Indian Nutraceuticals Market Forecast to 2017
6. Liproxenol Nutraceuticals Adds to Collection of Weight Loss Industry Awards
7. Prescopodene Nutraceuticals named to “Best Diet Pills of 2012” list
8. Fertility Nutraceuticals, LLC Announces Partnership with Austin Marketing Agency Space Chimp Media
9. Special Deals For Viton O-rings Wholesalers Worldwide Just Announced By Silicone Mold Manufacturer
10. A New Copper Bracelet for Pain Relief Announced Superior Magnetics
11. Cheap iPhone 5 Cases Just Announced by, A Popular Fashion Store
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... Dental Association meeting in Washington D.C. revolved around the fact that proper dental care, ... The talk stressed the link between periodontal disease (more commonly referred to as gum ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the ... Table 1-1 ). More than 3.7 billion people under the age of 50 ... (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The data ...
(Date:11/27/2015)... ... 2015 , ... Keeping in mind challenges faced by parents ... consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for children ... and bring advice from parenting experts within their reach. As a part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
Breaking Medicine Technology: